Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference2%
- Check19 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, indicating a new release with presumably added features or fixes.SummaryDifference0.0%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 (new release). The 'Back to Top' link was removed.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has added significant content related to renal cell carcinoma, including new studies and analyses, while removing some previous location and drug-related terms. Notably, the facility name and location have been updated.SummaryDifference9%
- Check62 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.